Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder
The Journal of Clinical Psychiatry · 25.08.2025 · 86 (4)
DOI: 10.4088/jcp.25m15848 ↗Kurz gefasst
Randomisierte kontrollierte Studie in der Zeitschrift The Journal of Clinical Psychiatry, online erschienen am 25.08.2025. Verfasst von Suresh Durgam und 6 weiteren Autor:innen. Beteiligte Einrichtung: Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, New Jersey. Hauptthemen laut MEDLINE: Major Depressive Disorder, Antidepressive Agents, Antipsychotic Agents. Die Arbeit wurde bisher 10-mal zitiert (Crossref).
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Intra-Cellular Therapies, a Johnson & Johnson Company, Bedminster, New Jersey.
- Corresponding Author: Suresh Durgam, MD, Intra-Cellular Therapies, a Johnson & Johnson Company, 135 US Highway 202/206, Ste 6, Bedminster, NJ 07921 (sdurgam@itci-inc.com).
- Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada.
- Department of Psychiatry, University of California, San Diego and Riverside; La Jolla, California.
Zitieren
APA
Durgam, S., Earley, W. R., Kozauer, S. G., Chen, C., Lakkis, H., McIntyre, R. S., & Stahl, S. (2025). Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry, 86(4). https://doi.org/10.4088/jcp.25m15848
Vancouver
Durgam S, Earley WR, Kozauer SG, Chen C, Lakkis H, McIntyre RS, et al. Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder. The Journal of Clinical Psychiatry. 2025;86(4). doi:10.4088/jcp.25m15848
BibTeX
@article{Durgam2025,
author = {Durgam, Suresh and Earley, Willie R and Kozauer, Susan G and Chen, Changzheng and Lakkis, Hassan and McIntyre, Roger S and Stahl, Stephen},
title = {Lumateperone as Adjunctive Therapy in Patients With Major Depressive Disorder},
journal = {The Journal of Clinical Psychiatry},
year = {2025},
volume = {86},
number = {4},
doi = {10.4088/jcp.25m15848}
}
EUVIMED